{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:50:12Z","timestamp":1790700612404,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["81671594"],"award-info":[{"award-number":["81671594"]}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["81571591"],"award-info":[{"award-number":["81571591"]}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2019309067"],"award-info":[{"award-number":["2019309067"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.intimp.2018.12.026","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:56:02Z","timestamp":1545425762000},"page":"372-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Association of CCL11, CCL24 and CCL26 with primary biliary cholangitis"],"prefix":"10.1016","volume":"67","author":[{"given":"Feng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhencheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renqian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10003","key":"10.1016\/j.intimp.2018.12.026_bb0005","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2018.12.026_bb0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/VHHD-HTRU-N8J2-5X7R","article-title":"Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis","volume":"116","author":"Goldstein","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.intimp.2018.12.026_bb0015","first-page":"2245","article-title":"Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis","volume":"92","author":"Nakamura","year":"1997","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2018.12.026_bb0020","first-page":"516","article-title":"Eosinophilia in primary biliary cirrhosis","volume":"91","author":"Yamazaki","year":"1996","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.026_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.510300121","article-title":"Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis","volume":"30","author":"Yamazaki","year":"1999","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.intimp.2018.12.026_bb0030","first-page":"810","article-title":"Eosinophilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid","volume":"124","author":"Wirth","year":"1994","journal-title":"Schweiz. Med. Wochenschr."},{"issue":"2","key":"10.1016\/j.intimp.2018.12.026_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-005-0090-0","article-title":"New chemokine targets for asthma therapy","volume":"5","author":"Garcia","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.intimp.2018.12.026_bb0040","first-page":"1253","article-title":"An overlook to the characteristics and roles played by eotaxin network in the pathophysiology of food allergies: allergic asthma and atopic dermatitis","volume":"39","author":"Ahmadi","year":"2016","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.intimp.2018.12.026_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cyto.2012.07.001","article-title":"Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients","volume":"60","author":"Papli\u0144ska","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.intimp.2018.12.026_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2249.2011.04464.x","article-title":"Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid","volume":"166","author":"G\u00fcnther","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2018.12.026_bb0055","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","article-title":"Eotaxin-3 is involved in Churg-Strauss syndrome\u2014a serum marker closely correlating with disease activity","volume":"47","author":"Polzer","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.intimp.2018.12.026_bb0060","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.cgh.2014.06.019","article-title":"Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study","volume":"12","author":"Dellon","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2018.12.026_bb0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jir.2013.0075","article-title":"Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis","volume":"34","author":"Landi","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.026_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2018.12.026_bb0080","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.intimp.2018.12.026_bb0085","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.intimp.2018.12.026_bb0090","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc. R. Soc. Med."},{"issue":"8","key":"10.1016\/j.intimp.2018.12.026_bb0095","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1440-1746.2006.04621.x","article-title":"Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course","volume":"22","author":"Tacke","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2018.12.026_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000598","article-title":"Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis","volume":"4","author":"Burke","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2018.12.026_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12642","article-title":"Plasma levels of innate immune mediators are associated with liver fibrosis in low parasite burden Schistosoma mansoni-infected individuals","volume":"87","author":"Rodrigues Oliveira","year":"2018","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2018.12.026_bb0110","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10096-010-0981-4","article-title":"Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection","volume":"29","author":"Moura","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2018.12.026_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clim.2014.04.012","article-title":"From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation","volume":"153","author":"Adar","year":"2014","journal-title":"Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918313328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918313328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:10:00Z","timestamp":1761585000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918313328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":22,"alternative-id":["S1567576918313328"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.026","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of CCL11, CCL24 and CCL26 with primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}